Deerfield Management Company, L.P. (Series C) Profound Medical Corp. Transaction History

Deerfield Management Company, L.P. (Series C)

  • $5.38 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$3.99 - $9.3 $3.92 Million - $9.13 Million
-981,254 Reduced 57.26%
732,543 $2.96 Million
Q4 2021

Feb 14, 2022
BUY
$10.38 - $15.2 $4.32 Million - $6.32 Million
416,000 Added 32.05%
1,713,797 $19.2 Million
Q1 2021

May 17, 2021
BUY
$19.16 - $28.09 $11.5 Million - $16.9 Million
602,797 Added 86.73%
1,297,797 $26.1 Million
Q3 2020

Nov 16, 2020
BUY
$14.05 - $18.13 $9.76 Million - $12.6 Million
695,000 New
695,000 $12.3 Million

Others Institutions Holding PROF

# of Institutions
45
Shares Held
8.93M
Call Options Held
1.2K
Put Options Held
5K
View Full List

About Profound Medical Corp.

PROF Quotes by TradingView
  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $157M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email